JNJ vs RMD
By Alex · Tickerpine
Johnson & Johnson vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | RMD |
|---|---|---|
| Price | $285.75 | $239.53 |
| Market cap | $687.89B | $33.69B |
| P/E ratio | 43.4 | 21.8 |
| ROE | 20.02% | 26.40% |
| Profit margin | 16.20% | 27.79% |
| Revenue growth | 5.90% | 5.90% |
| Dividend yield | 1.88% | 1.10% |
| Beta | 0.20 | 0.76 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs RMD in plain English
- JNJ is the bigger company — about 20.4× the market cap of RMD.
- RMD is cheaper on earnings (P/E 21.8 vs 43.4).
- RMD earns a higher return on equity (26% vs 20%).
- RMD is growing revenue faster (6% vs 6%).
- JNJ has the higher dividend yield (1.88% vs 1.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.